Terms of Service

Last Updated: January 11, 2026

PharmaLens is NOT a registered investment advisor, dealer, broker-dealer, or financial planner. We are NOT registered with any Canadian securities commission, the U.S. Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), or any other regulatory authority.

The reports, analyses, and information provided through this platform are for informational and educational purposes ONLY. They do NOT constitute financial advice, investment advice, trading advice, or any other type of professional advice.

You should NOT rely solely on information from PharmaLens to make investment decisions. Always conduct your own thorough due diligence and consult with qualified financial professionals before making any investment decisions.

We make NO WARRANTIES regarding the accuracy, completeness, or timeliness of any information provided. Biotech and pharmaceutical investments carry significant risks, including total loss of capital.

Past performance is not indicative of future results. Clinical trial outcomes, regulatory decisions, and market performance are inherently unpredictable.

Information is sourced from publicly available third-party sources. We do not independently verify the accuracy of all information and assume no responsibility for errors or omissions in source data.

BY USING THIS SERVICE, YOU ACKNOWLEDGE THAT:

  • Any investment decisions are made entirely at your own risk
  • You will not hold PharmaLens liable for investment losses
  • You have read and understood this disclaimer

1. Acceptance of Terms

By accessing or using PharmaLens ("the Service"), you agree to be bound by these Terms of Service ("Terms"). If you do not agree to these Terms, you may not use the Service.

These Terms constitute a legally binding agreement between you and PharmaLens. Your use of the Service confirms your acceptance of these Terms.

2. Description of Service

PharmaLens is a biotech intelligence platform that provides information and analysis on pharmaceutical and biotechnology companies, drug candidates, clinical trials, and related market data. The Service generates reports by aggregating and analyzing publicly available information.

The Service is designed for informational and educational purposes only. It is not designed to provide, and should not be relied upon for, financial, investment, legal, or other professional advice.

3. User Obligations and Prohibited Conduct

You agree to use the Service only for lawful purposes. You agree NOT to:

  • Use the Service to make investment decisions without conducting your own independent due diligence
  • Share your account credentials with others
  • Resell, redistribute, or commercially exploit reports or data from the Service
  • Use automated systems (bots, scrapers) to access the Service without authorization
  • Attempt to circumvent security features or access controls
  • Violate any securities laws or regulations using information from the Service
  • Use the Service in any way that could damage, disable, or impair the Service
  • Upload or transmit viruses, malware, or other malicious code

4. Data Accuracy and Third-Party Sources

Information provided through the Service is sourced from publicly available third-party sources, including but not limited to: company filings, clinical trial registries (ClinicalTrials.gov), regulatory databases, scientific publications, and financial disclosures.

WE DO NOT INDEPENDENTLY VERIFY ALL INFORMATION and assume no responsibility for errors, omissions, or inaccuracies in source data. Third-party data may be outdated, incomplete, or incorrect.

Reports are generated using artificial intelligence and may contain errors. You are responsible for verifying any information included in the reports.

5. No Warranty

THE SERVICE IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO:

  • Warranties of merchantability or fitness for a particular purpose
  • Warranties of accuracy, completeness, or timeliness of information
  • Warranties of uninterrupted or error-free operation
  • Warranties that defects will be corrected

We do not warrant that the Service will meet your requirements or that reports will be accurate, complete, or suitable for your needs.

6. Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW, PHARMALENS SHALL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO:

  • Investment losses or lost profits
  • Business interruption or loss of business opportunity
  • Loss of data or cost of substitute services
  • Errors or inaccuracies in reports
  • Service interruptions or downtime

This limitation applies WHETHER OR NOT we have been advised of the possibility of such damages, and regardless of the legal theory (contract, tort, negligence, strict liability, or otherwise).

IN NO EVENT SHALL OUR TOTAL LIABILITY TO YOU EXCEED THE AMOUNT YOU PAID FOR THE SERVICE DURING THE TWELVE (12) MONTHS PRECEDING THE CLAIM.

Some jurisdictions do not allow the exclusion or limitation of certain damages, so some of the above limitations may not apply to you.

7. Indemnification

You agree to indemnify, defend, and hold harmless PharmaLens, its officers, directors, employees, contractors, and agents from any and all claims, damages, losses, liabilities, and expenses (including reasonable attorneys' fees) arising from:

  • Your use of the Service
  • Investment decisions made based on information obtained through the Service
  • Your violation of these Terms
  • Your violation of any rights of another party
  • Your violation of any applicable laws or regulations

8. Intellectual Property

All content, software, designs, text, graphics, and other materials provided through the Service (excluding third-party data and publicly available information) are owned by or licensed to PharmaLens. All rights are reserved.

You are granted a limited, non-exclusive, non-transferable license to access and use the Service for your personal or internal business purposes only. You may not:

  • Copy, modify, or create derivative works of the Service or its content
  • Distribute, sell, resell, rent, lease, or sublicense access to the Service
  • Reverse engineer, decompile, or disassemble any software or technology underlying the Service
  • Remove or alter any copyright, trademark, or other proprietary notices
  • Use the Service or its content for any commercial purpose outside of your subscription

Reports generated through the Service are licensed to you for your use in accordance with your subscription plan. You may not redistribute reports to third parties or use them for commercial resale.

9. Subscription and Billing

The Service is provided on a subscription basis. You agree to pay all fees associated with your subscription plan. Fees are billed in advance on a recurring basis (monthly).

We reserve the right to change our pricing at any time. Price changes will be communicated in advance and will apply to subsequent billing periods.

You may cancel your subscription at any time. Cancellations take effect at the end of the current billing period. No refunds are provided for partial billing periods.

10. Termination

We reserve the right to suspend or terminate your access to the Service at any time, with or without cause, with or without notice, including for violation of these Terms.

Upon termination, your right to use the Service will immediately cease. Provisions of these Terms that by their nature should survive termination (including indemnification, limitation of liability, and governing law) will survive.

11. Governing Law and Dispute Resolution

Governing Law

These Terms shall be governed by and construed in accordance with the laws of the Province of Ontario and the federal laws of Canada applicable therein, without regard to conflict of law principles. This choice of law applies to all users regardless of their location.

Mandatory Arbitration

Any dispute, controversy, or claim arising out of or relating to these Terms or your use of the Service shall be resolved by binding arbitration. The arbitration shall be conducted:

  • For Canadian users: In accordance with the Arbitration Act, 1991 (Ontario), conducted in English in Toronto, Ontario
  • For U.S. users: In accordance with the Commercial Arbitration Rules of the American Arbitration Association (AAA), conducted in English at a location mutually agreed upon by both parties or via online/virtual arbitration

The arbitration shall be before a single arbitrator appointed in accordance with the applicable arbitration rules. The arbitrator's decision shall be final and binding on both parties. Each party shall bear its own costs of arbitration unless the arbitrator determines otherwise.

Class Action Waiver

YOU AGREE THAT ANY ARBITRATION OR LEGAL PROCEEDING SHALL BE CONDUCTED ON AN INDIVIDUAL BASIS ONLY, and not as a class action, consolidated action, or representative action. You waive any right to participate in a class action lawsuit or class-wide arbitration against PharmaLens.

This class action waiver applies to all users in all jurisdictions to the maximum extent permitted by law. If this waiver is found to be unenforceable in your jurisdiction, the arbitration agreement may not apply to you, and disputes shall be resolved in the courts as specified below.

Exceptions to Arbitration

Notwithstanding the above arbitration provisions, either party may:

  • Seek equitable relief (such as injunctions or specific performance) in a court of competent jurisdiction to protect intellectual property rights
  • Bring claims in small claims court if the claim qualifies
  • Seek remedies in court if the arbitration agreement is found to be unenforceable

Jurisdiction and Venue (If Arbitration Does Not Apply)

If for any reason the arbitration provision does not apply, you agree that any legal action or proceeding shall be brought exclusively in the courts located in Toronto, Ontario, Canada, and you consent to the personal jurisdiction of such courts.

12. Changes to Terms

We reserve the right to modify these Terms at any time. We will provide notice of material changes by posting the updated Terms on this page and updating the "Last Updated" date.

Your continued use of the Service after changes become effective constitutes your acceptance of the revised Terms. If you do not agree to the modified Terms, you must stop using the Service.

13. Miscellaneous

Entire Agreement: These Terms constitute the entire agreement between you and PharmaLens regarding the Service and supersede all prior agreements.

Severability: If any provision of these Terms is found to be unenforceable, the remaining provisions will remain in full force and effect.

Waiver: Our failure to enforce any provision of these Terms shall not constitute a waiver of that provision or any other provision.

Assignment: You may not assign or transfer these Terms without our prior written consent. We may assign these Terms without restriction.

14. Contact Information

For questions about these Terms, please contact us at:

Email: legal@pharmalens.com

Stop Waiting for Research. Generate It.
Comprehensive due diligence reports on biotech companies and drug candidates built for investors.
LogoPharmaLens
    © Copyright 2026 PharmaLens.